Immunomodulatory effects of mesenchymal stem cells derived from the bone marrow in acute leukemia patients

Chinese Journal of Oncology

Volumn 33, Issue 2, 2011, Pages 105-109

  Zhao, Zhi Gang ^a   Sun, Li ^a   Wang, Xiao Fang ^a   Zhang, Yi Zhuo ^a   Yu, Yong ^a   Yang, Hong Liang ^a   Zou, Ping ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute; Cytokines; Leukemia; Lymphocytic; Mesenchymal stem cell; Myeloid; T lymphocytes

Indexed keywords

B7 ANTIGEN; BETA1 INTEGRIN; CD31 ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CYTOKINE; ENDOGLIN; HERMES ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 11; INTERLEUKIN 6; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CANCER PATIENT; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPHENOTYPING; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; T LYMPHOCYTE; BONE MARROW CELL; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM;

BONE MARROW; BONE MARROW CELLS; CELL PROLIFERATION; CYTOKINES; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-11; INTERLEUKIN-6; LEUKEMIA, MYELOID, ACUTE; MESENCHYMAL STROMAL CELLS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80053424868     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2011.02.006     Document Type: Article

References (12)

1. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002, 418:41-49. (Pubitemid 34742565)
2. + cells in NOD/SCID mice. Exp Hematol, 2002, 30:870-878.
3. Koc ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol, 2000, 18:307-316. (Pubitemid 30056419)
4. Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood, 2003, 101:3722-3729. (Pubitemid 36857965)
5. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002, 30:42-48. (Pubitemid 34059216)
6. Sayegh MH, Carpenter CB. Transplantation 50 years later: progress, challenges, and promises. N Engl J Med, 2004, 351:2761-2766. (Pubitemid 39665333)
7. Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 2005, 11:389-398. (Pubitemid 40542932)
8. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 2004, 363:1439-1441. (Pubitemid 38586721)
9. Le Blanc K, Rasmusson I, Götherström C, et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol, 2004, 60:307-315. (Pubitemid 39141263)
10. Devine SM, Bartholomew AM, Mahmud N, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol, 2001, 29:244-255. (Pubitemid 32112325)
11. Koc ON, Day J, Nieder M, et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant, 2002, 30:215-222. (Pubitemid 35023593)
12. Zhao ZG, Liang Y, Li K, et al. Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases. Stem Cells Dev, 2007, 16:637-648. (Pubitemid 47378736)